| Date Filed | Type | Description |
| 08/10/2023 |
4
| Stelzer Laurie (CFO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 22,297 shares
@ $37, valued at
$825k
|
|
| 06/12/2023 |
4
| Stelzer Laurie (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 21,500 options to buy
@ $5.59, valued at
$120.2k
|
|
| 06/02/2023 |
4
| Stelzer Laurie (CFO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Sold 4,647 shares
@ $37.06, valued at
$172.2k
|
|
| 01/24/2023 |
4
| Stelzer Laurie (CFO) has filed a Form 4 on Mirati Therapeutics, Inc.|
Txns:
| Granted 26,864 shares
@ $0
Granted 45,456 options to buy
@ $45.66, valued at
$2.1M
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/06/2022 |
4
| Stelzer Laurie (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.|
Txns:
| Granted 19,500 options
@ $13.56, valued at
$264.4k
|
|
| 06/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/16/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 03/11/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2022 |
4
| Stelzer Laurie (EVP & CFO) has filed a Form 4 on ARENA PHARMACEUTICALS INC|
Txns:
| Granted 21,462 shares
@ $0 |
|
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/02/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/24/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/12/2020 |
4
| Stelzer Laurie (Director) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 12,000 options to buy
@ $4.35, valued at
$52.2k
|
|
| 03/17/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/17/2020 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 02/24/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/18/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/12/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2019 |
4
| Stelzer Laurie (SVP, CFO) has filed a Form 4 on HALOZYME THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 3,408 shares
@ $15.73, valued at
$53.6k
Exercised 6,875 restricted stock units
@ $0 |
|
| 06/06/2019 |
4
| Stelzer Laurie (Director) has filed a Form 4 on Surface Oncology, Inc.|
Txns:
| Granted 12,100 options to buy
@ $3.69, valued at
$44.6k
|
|
| 02/22/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/15/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/14/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/05/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/18/2018 |
4
| Stelzer Laurie (SVP, CFO) has filed a Form 4 on HALOZYME THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 3,254 shares
@ $19.02, valued at
$61.9k
Exercised 6,875 restricted stock units
@ $0 |
|
| 04/18/2018 |
3
| Stelzer Laurie (Director) has filed a Form 3 on Surface Oncology, Inc. |
| 02/23/2018 |
4
| Stelzer Laurie (SVP, CFO) has filed a Form 4 on HALOZYME THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 3,939 shares
@ $19.28, valued at
$75.9k
Exercised 11,392 restricted stock units
@ $0 |
|
| 02/16/2018 |
4
| Stelzer Laurie (SVP, CFO) has filed a Form 4 on HALOZYME THERAPEUTICS INC|
Txns:
| Granted 54,780 options to buy
@ $18.41, valued at
$1M
Granted 31,234 restricted stock units
@ $0 |
|
| 02/05/2018 |
4
| Stelzer Laurie (SVP, CFO) has filed a Form 4 on HALOZYME THERAPEUTICS INC|
Txns:
| Paid exercise price by delivering 8,265 shares
@ $18.37, valued at
$151.8k
Exercised 23,120 restricted stock units
@ $0 |
|
|